p53 Autoantibodies Predict Subsequent Development of Cancer
-
2005/03/01
-
Details
-
Personal Author:Brandt-Rauf PW ; Hemminki K ; Karjalainen A ; Koskinen H ; Li Y ; Pukkala E ; Shnaidman M ; Vainio H ; Ying Z
-
Description:Because TP53 mutations can induce an immune response and can occur early in the carcinogenic process for some tumors, p53 autoantibodies may be useful biomarkers for risk of development of cancer. Using banked serum samples from an asbestosis cohort at high risk for cancer, we demonstrate for the first time a statistically significant relationship between p53 autoantibodies and the subsequent development of malignancy (hazard ratio [HR] = 5.5, 95% confidence interval [CI] = 2.8-10.9) with a positive predictive value of 0.76 and an average lead time to diagnosis of 3.5 years. p53 autoantibodies were also significantly associated with p53 alterations in the resultant tumors (kappa = 0.78, p = 0.01). [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0020-7136
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:157-160
-
Volume:114
-
Issue:1
-
NIOSHTIC Number:nn:20028856
-
Citation:Int J Cancer 2005 Mar; 114(1):157-160
-
Contact Point Address:Paul W. Brandt-Rauf, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 60 Haven Avenue, New York, NY 10032
-
Email:pwb1@columbia.edu
-
Federal Fiscal Year:2005
-
NORA Priority Area:
-
Performing Organization:Columbia University Health Sciences
-
Peer Reviewed:True
-
Start Date:20020601
-
Source Full Name:International Journal of Cancer
-
End Date:20110630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d3614420613bbf2b14a4c7389aea583860aa376505712c666e60ad15abf53852d293c2aa2f267518dfeabfb3c75aa873ad490d8949d61d29ad5a414aef06e121
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like